Google
BBNX — BETA BIONICS, INC. COMMON STOCK (Healthcare >> Medical Devices)
BBNX FAQ
What is BBNX's ROE?
BETA BIONICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -24.49%.
What is BBNX's dividend yield?
BETA BIONICS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is BBNX's Deepscope Quality Score?
Deepscope rates BBNX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BBNX?
Deepscope's AI Timing Score for BBNX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BBNX belong to?
BETA BIONICS, INC. COMMON STOCK is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 14.53
Price
-0.16
(-1.09%)
Day Change
|
|
|---|
BBNX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 14.53 |
| PBV / Sector |
2.41 / 7.44
|
| Earning Per Share | -1.47 |
| PE / Sector |
N/A / 29.54
|
| PEG or PE/Growth / Sector |
N/A / 0.40
|
| Average 1M Daily Value |
11.35 M
GREAT
|
| Average 1W Daily Value |
16.31 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-13 11:13:58 |
| Symbol | BBNX |
| Name | BETA BIONICS, INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 44.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 654.61 / 18,290.40 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 11 Hughes, Irvine, CA, United States, 92618
Phone: 949 427 7785
Website: https://www.betabionics.com
Employees: 420
Sector: Healthcare >> Medical Devices
Description: Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
